Anthropic has appointed Vas Narasimhan, chief executive of Swiss pharmaceutical company Novartis NOVN 0.56%increase; green up pointing triangle, to its board of directors, its second new board addition in recent months.
The company is strengthening its board as it eyes an initial public offering, potentially as soon as this year, and as it expands its enterprise push into healthcare. The developer of the Claude chatbot added Chris Liddell, the former Microsoft and General Motors executive, to its board in February.
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8